Verbatim response from ChatGPT
Short answer: For most people who need systemic estrogen, transdermal estrogen (patch/gel) is generally safer than oral estrogen for blood-clot and some cardiovascular risks. But the best choice depends on your health history, symptoms, and preferences — discuss with your clinician.
Why transdermal (patch/gel) is often safer
- Bypasses first-pass liver metabolism, so it has less effect on liver-made clotting factors, CRP and triglycerides. That is why transdermal estradiol is associated with a lower risk of venous thromboembolism (VTE) and probably a lower stroke risk than oral estrogens in most observational studies.
- Good option if you have VTE risk factors (history of VTE, obesity, age, smoking, genetic thrombophilia), or if you have high triglycerides or certain liver issues.
Why oral estrogen can carry higher risk
- Oral estrogens (conjugated estrogens or oral estradiol) go through the liver first, raising clotting factors, sex‑hormone binding globulin (SHBG), CRP and triglycerides, which is linked to a higher VTE risk and possibly higher stroke risk compared with transdermal.
- Oral pills are convenient and often less expensive, and some women tolerate them better.
Other safety and practical points
- If you still have a uterus, estrogen must be combined with a progestogen to prevent endometrial hyperplasia/cancer. Progestogen can be given orally (micronized progesterone) or via a levonorgestrel IUD (Mirena), which is often preferred for targeted progestin delivery.
- Local low‑dose vaginal estrogen (cream, ring, tablet) is safest for isolated vaginal symptoms and has minimal systemic exposure.
- Side effects: patches/gel can cause local skin irritation or adhesion problems; pills can cause nausea or liver-related effects.
- Absolute contraindications to systemic estrogen include active or recent VTE, untreated estrogen-sensitive cancer, active liver disease, and some forms of cardiovascular disease — so individual risk assessment is essential.
Brand examples (to discuss with your clinician)
- Transdermal patches: Vivelle‑Dot (estradiol patch), Climara (estradiol patch), Alora — commonly used, steady delivery, lower systemic clot risk.
- Transdermal gel: EstroGel, Divigel — alternative if you prefer not to use patches.
- Oral pills: Estrace (micronized 17β‑estradiol) and Premarin (conjugated equine estrogens) — familiar oral options; be aware of higher first‑pass effects.
- Progestogen options: Prometrium (micronized progesterone oral) or Mirena (levonorgestrel IUD) for endometrial protection.
What to do next
- Talk with your clinician about your age, time since menopause, personal and family history (VTE, stroke, heart disease, breast cancer), smoking and BMI. If clot risk is a concern, transdermal formulations are usually preferred.
- If you want, tell me a bit about your health history and symptoms and I can summarize the pros/cons specific to you.